Venture capital runs on a simple, brutal logic: deploy capital, chase outliers, return the fund. But in health tech, that math keeps breaking down. Long regulatory timelines, complex reimbursement structures, and sales cycles that stretch years don't fit neatly into a 10-year fund lifecycle — and the industry is starting to reckon with that misalignment.
Health Tech VC Is Broken. One Investor Is Rewriting the Rules.
The standard venture playbook wasn't built for health tech — and some investors are finally admitting it. Here's what a new model could look like.
This is a Pro article
Subscribe to read the full article and support independent AI journalism.